Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Adenoscan (Adenosine) Injection, Fujisawa Healthcare, NDA 20-059/S7 8/31/01 11/5/01 11/5/01 11/7/01 Adenoscan Indications: Adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Adenosine Injection, 3 mg/mL, Sicor ANDA 76-564 9/23/03 Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-500 5/14/03 Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-501 5/14/03 Adenosine Injection, 3 mg/mL, 2 mL & 4 mL, Bedford ANDA 76-404   For the latest approval information, locate this drug using this index.